SEC Form 4 · accession 0000874015-15-000049
IONIS PHARMACEUTICALS INC · IONS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
B Lynne Parshall
Officer — COO & Secretary · Director
Period of report
Apr 1, 2015
Accepted (ET)
Apr 6, 2015 · 11:51 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 1, 2015 | M | 5,377 | $14.69 | A | 13,449 | D | |
| Common StockF1 | Apr 1, 2015 | S | 5,377 | $61.9321 | D | 8,072 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $14.69 | Apr 1, 2015 | M | 5,377 | D | Jan 2, 2014 | Jan 29, 2020 | Common Stock | 5,377 | 43,193 | D |
Explanation of responses
- F1Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on 7/29/2014.
- F2Grant of 1/30/2013 to reporting person of stock options under the Isis Pharmacueticals, Inc. 1989 Stock Option Plan. 25% of the shares subject to the option vested and became exercisable on 1/2/2014. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 15,570 shares per year. Following this transaction, the option was exercisable as to 14,648 on 4/1/2015.